6.3x ROAS on Programmatic Spend: How MassMetric's AI-Powered Programmatic Engine Drove 340% Pipeline Growth for an Australian HealthTech Leader 

6.3x ROAS | 340% ↑ Pipeline | 72% ↓ Cost Per Opportunity | 89% AU Decision-Maker Coverage 

An Australian HealthTech leader with FDA-cleared AI diagnostics struggled to penetrate healthcare systems despite clinical excellence. Generic programmatic campaigns delivered 69% of impressions to non-decision-makers, resulting in 10.2-month sales cycles, 17% MQL-to-SQL conversion, and $7,100 cost per qualified opportunity. 

MassMetric transformed this with its AI-powered programmatic engine, MassMomentum, fusing precision targeting with exclusive publisher access across Business World IT and TechFunnel AU. Campaigns targeted hospital CIOs, Clinical Directors, and Health IT leaders with verified intent signals for AI-assisted diagnostics, using pre-syndication hashed email audiences and closed-loop attribution to prove deterministic pipeline impact. 

The outcome? A 6.3x ROAS on programmatic spend within 5 months, 340% increase in qualified pipeline, 72% reduction in cost per opportunity ($7,100 → $1,990), and 58% faster sales velocity through precise audience targeting—all while ensuring 89% of opportunities originated from AU-based decision-makers with verified ABN. 

This case proves that in healthcare, AI-powered programmatic intelligence beats generic reach—and precision targeting converts market fragmentation into competitive advantage. 

What You'll Learn from This Case

1. How AI-powered intent signals unlock high-propensity healthcare accounts with 92% targeting accuracy

2. Why publisher-integrated programmatic builds credibility where open exchanges fail

3. How multi-stakeholder orchestration (CIO, Clinical Director, Procurement) accelerates consensus in complex sales cycles

4. The ROI of precision audience architecture—not just budget or authority 

Discover how AI-powered programmatic intelligence turned market fragmentation into $2.8M in attributable pipeline